KM SULLIVAN, R STORB, HM SHULMAN, … - Annals of Internal Medicine, 1982 - Am Coll Physicians Twenty-four patients, including two with aplastic anemia and 22 with malignancy,
underwent marrow transplantation after preparation with mechlorethamine, 0.3 to
2.0 mg/kg body weight. Fourteen of the 21 neurologically evaluable ... Cited by 22 - Related articles - All 3 versions
[CITATION] Differential diagnosis of neurological complications in bone marrow transplantation
B Gordon, E Lyden, J Lynch, S Tarantolo, ZS … - Bone marrow transplantation(Basingstoke), 2000 - cat.inist.fr Development of CNS dysfunction in the setting of hematopoietic stem cell
transplant(HSCT) has been previously shown to predict for subsequent second
organ dysfunction and death. In this paper, we describe the characteristics ... Cited by 13 - Related articles - BL Direct - All 2 versions
WD Haire - Seminars in thrombosis and hemostasis, 1999 - thieme-connect.com In the past two decades, major improvements in antibiotics and other elements of
supportive care have decreased the number and severity of complications of
hematopoietic stem cell transplantation (HSCT). Despite these improvements, ... Cited by 8 - Related articles - All 4 versions
[CITATION] Myeloablative chemotherapy with autologous bone marrow rescue for patients with recurrent …
[CITATION] Bone marrow (hematopoietic cell) transplantation
SJ Forman, H Openshaw - … Complications in Organ Transplant Recipients: Blue …, 1999 - Butterworth-Heinemann Medical Cited by 3 - Related articles - BL Direct
HI Tahsildar, BF Remler, RJ Creger, BW … - Journal of neuro-oncology, 1996 - Springer HI Tahsildar, 1 BE Remler, 2'3 RJ Creger, 1 BW Cooper, 1 SM Snodgrass, 2 RW Tarr
4 and HM Lazarus 1 The Ireland Cancer Center, Departments of 1 Medicine, 2
Neurology, ~ Ophthalmology, and 4 Radiology, Uni- versity Hospitals of ... Cited by 4 - Related articles - BL Direct - All 3 versions
NR Anderson, DS Tandon - CA A Cancer Journal for Clinicians - interscience.wiley.com Ifosfamide-associated central nervous system toxicity has been reported in 5% to
30% of patients treated with ifosfamide. Its pattern is characterized by
metabolic encephalopathy with confusion, blurred vision, mutism, auditory ... Cited by 21 - Related articles - All 3 versions
K Atkinson, H Clink, S Lawler, DN Lawson, … - European journal of cancer, 1977 - ncbi.nlm.nih.gov 1: Eur J Cancer. 1977 Jun;13(6):623-5. Encephalopathy following bone marrow
transplantation. Atkinson K, Clink H, Lawler S, Lawson ... Cited by 8 - Related articles
JP Curtin, PP Koonings, M Gutierrez, JB … - Gynecologic oncology, 1991 - ncbi.nlm.nih.gov Ifosfamide is an active chemotherapeutic agent in a wide range of gynecologic
tumors; favorable response rates have been reported in ovarian (epithelial and
germ cell), uterine, and cervical neoplasms. Central neurotoxicity is a ... Cited by 28 - Related articles - All 3 versions
